Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sunshine Biopharma Inc.

    NASDAQ: SBFM · Real-Time Price · USD
    1.45
    -0.02 (-1.36%)
    At close: Jun 27, 2025, 3:58 PM
    1.50
    3.81%
    After-hours: Jun 27, 2025, 04:45 PM EDT
    -1.36%
    Bid 1.33
    Market Cap 6.58M
    Revenue (ttm) 34.87M
    Net Income (ttm) -5.13M
    EPS (ttm) -5.76
    PE Ratio (ttm) -0.25
    Forward PE n/a
    Analyst Buy
    Ask 1.6
    Volume 76,194
    Avg. Volume (20D) 1,472,906
    Open 1.42
    Previous Close 1.47
    Day's Range 1.40 - 1.50
    52-Week Range 1.17 - 9.20
    Beta 0.96

    About SBFM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol SBFM
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for SBFM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 months ago
    +3.2%
    Sunshine Biopharma shares are trading higher after... Unlock content with Pro Subscription
    2 months ago
    +8.17%
    Sunshine Biopharma shares are trading higher after the company reported a year-over-year increase in FY24 revenue results.
    news image

    2 weeks ago · accessnewswire.com

    Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

    FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...

    news image

    1 month ago · accessnewswire.com

    Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

    FORT LAUDERDALE, FL / ACCESS Newswire / May 15, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of th...

    news image

    1 month ago · accessnewswire.com

    Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

    FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ther...

    news image

    2 months ago · accessnewswire.com

    Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

    FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic area...

    news image

    2 months ago · accessnewswire.com

    Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

    FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...

    news image

    2 months ago · accessnewswire.com

    Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

    FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...

    news image

    2 months ago · benzinga.com

    Sunshine Biopharma Stock Shoots Higher On Encouraging Data From mRNA-Based Liver Cancer Drug

    Sunshine Biopharma Inc. SBFM traded higher on Wednesday, with a session volume of 19.07 million compared to an average volume of 88.16K, according to data from Benzinga Pro.

    news image

    2 months ago · accessnewswire.com

    Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

    FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a pharmaceutical company offering and researching life-saving medicines in a...

    news image

    2 months ago · accessnewswire.com

    Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

    FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of t...

    Add to Watchlist